Introduction
The nuclear factor kappa B (NF-kB) transcription factor is ubiquitous and is expressed in an inactive form in most cells where it is sequestered in the cytoplasm by an inhibitory protein belonging to the IkB family (IkBa, IkBb, IkBe, p100, p105 and Bcl-3) (Karin, 1999) . A large number of stimuli, including cytokines, infectious agents, oxidative stress or DNAdamaging agents can lead to the activation of NF-kB (Finco et al., 1997; Pahl, 1999) . Most stimuli, including Tumor Necrosis Factor a (TNF-a) and Interleukine-1b (IL-1b), induce phosphorylation, ubiquitination and degradation of IkBa, triggering the liberation of NFkB, which can then translocate to the nucleus and activate the transcription of its target genes (Karin, 1999) . These genes code for mediators of the immune and in¯ammatory responses, anti-and pro-apoptotic proteins, and growth factors (Pahl, 1999) . NF-kB has been shown to play an anti-apoptotic role in dierent cell types, as NF-kB activation protects in vitro several cell lines against apoptosis induced by TNF-a, ionizing radiation or daunorubicin (Van Antwerp et al., 1996; Beg and Baltimore, 1996; Wang et al., 1996 Wang et al., , 1999 Aggarwal, 2000) . However, other data showed that NF-kB activation is required for apoptosis, as, for instance, after p53 activation in cancer cells (Barkett and Gilmore, 1999; Ryan et al., 2000) TNF-a is one of the most potent and most studied NF-kB inducers. This cytokine has a pro-in¯ammatory role, but is also involved in immunoregulation, apoptosis, proliferation and anti-viral response (Fiers et al., 1988; Beyaert and Fiers, 1998) . TNF-a elicits these dierent responses by binding to two membrane receptors, TNFRI (p55) and TNFRII (p75). TNF-a binding to TNFRI leads to two intracellular pathways. First, an anti-apoptotic pathway induced by adaptor proteins TRADD, RIP and TRAF2, leading to the activation of NF-kB and AP-1, triggering pro-in¯am-matory responses. Second, a pro-apoptotic pathway, involving binding of the receptor adaptor FADD and pro-caspase-8 recruitment (Ashkenazi and Dixit, 1998) . A second pro-apoptotic response may occur by binding of RAIDD/CRADD, and further recruitment of caspase-2 (Duan and Dixit, 1997) .
It has also been shown that TNF-a may signal through ROS (reactive oxygen species) generation (Lo and Cruz, 1995; Lo et al., 1996) . The mitochondrial respiratory chain is the main source of TNF-a-induced ROS. Antioxidants inhibit some eects of TNF-a (cytotoxicity, gene expression, transcription factor activation) (Goossens et al., 1999) .
NF-kB cytoprotective role is related to the regulation of target genes regulating apoptosis, including Bcl-2 family members and Manganese Superoxide Dismutase (MnSOD) (Barkett and Gilmore, 1999; Pahl, 1999) . Bcl-2 related proteins regulate cell death and are divided in two subgroups (Larsen, 1994; Chao and Korsmeyer, 1998; Adams and Cory, 1998; Reed, 1998; Gross et al., 1999) . A cell survival-promoting group contains proteins sharing three to four conserved regions (Bcl-2 Homology Regions BH1 to BH4), while cell death inducers contain only two or three BH regions. Pro-and anti-apoptotic members of the Bcl-2 family can physically interact, and form hetero-or homo-dimers. Bcl-2 and Bcl-X L exert an anti-apoptotic role by maintaining the coupling of oxidative phosphorylation. They may also inhibit the release of cytochrome c and Apoptosis-Inducing Factor from mitochondria (Gross et al., 1999; Vander Heiden and Thompson, 1999) . NF-kB regulates the expression of Bcl-X L , B¯-1 and Bcl-2 itself. (Zong et al., 1999; Grumont et al., 1999; Lee et al., 1999; Feuillard et al., 2000; Chen et al., 2000) .
MnSOD is an enzyme localized in the mitochondrial matrix (Macmillan-Crow and Cruthirds, 2001) . It catalyzes the dismutation of the superoxide anion (O 2 .7 ) to hydrogen peroxide (H 2 O 2 ). It is estimated that between 1 and 3% of the O 2 reduced through the mitochondrial respiratory chain is transformed in O 2 .7 , which is dimutated by MnSOD. It is a nuclear encoded protein transported to the mitochondria via a targeting sequence, forming a native homotetrameric structure of 96 kDa. Deletion mutation of the MnSOD gene in mice resulted in death 5 ± 21 days after birth (Li et al., 1995a; Lebovitz et al., 1996) . Lipopolysaccharide (LPS) and cytokines including TNF-a, IL-1b and Interferon g (IFNg) may induce MnSOD expression (Gibbs et al., 1992; Jacoby and Choi, 1994; Gwinner et al., 1995; Ki¯e et al., 1996) . Overexpression of MnSOD has been shown to prevent the TNF-a-mediated activation of caspase-3 and apoptosis (Manna et al., 1998) . It might also protect the cells against apoptosis elicited by mitochondria-produced ROS. The role of MnSOD in cancer remains controversial. Many studies describe a lower MnSOD activity in tumor cells, while other investigators reported an increased MnSOD level in tumor cell lines (reviewed in Macmillan-Crow and Cruthirds, 2001) . Recently, it has been demonstrated that MnSOD gene expression can be regulated by a kB site localized in intron 2 (Xu et al., 1999; Darville et al., 2000; Bernard et al., 2001) .
In the present report, we investigate the role of NFkB and ROS in TNF-a-induced apoptosis and we demonstrate that NF-kB-regulated MnSOD expression prevents apoptosis in epithelial cancer cells.
Results

NF-kB exerts a cytoprotective role against TNF-ainduced apoptotic cell death
It has previously been shown that NF-kB exerts a cytoprotective eect against TNF-a-induced cell death.
OVCAR-3, MCF7A/Z and HCT116 epithelial cancer cells are resistant to TNF-a-induced apoptosis (Bentires-Alj et al., 1999) . To assess whether NF-kB is required for apoptosis resistance, we constructed cell lines expressing an IkBa inhibitor, where serines 32 and 36 have been mutated to alanines. In these cells, NFkB cannot be freed from its inhibitor, and does not have any biological activity. The transfected cells are referred to as MT OVCAR-3, MT MCF7A/Z, and MT HCT116.
Overexpression of a mutated form of IkBa prevents NF-kB nuclear translocation and activation in MT cells (Figure 1 ). Cytoplasmic extracts of control and IkBa-overexpressing OVCAR-3 and MCF7A/Z cells, unstimulated or TNF-a treated for 1 h (100 units/ml of culture medium) were used in Western blotting and revealed with an antibody directed against IkBa (Figure 1a) . These experiments showed high transgene expression. OVCAR-3 cells were transfected with an expression vector coding for a HA-tagged IkBa protein which migrates more slowly than the endogenous IkBa. In both cell lines, TNF-a induced the degradation of the endogenous IkBa but did not have any eect on the mutated exogenous protein. Figure 1b shows Electromobility shift assays (EMSA) performed with nuclear extracts of control and IkBa-overexpressing OVCAR-3 and MCF7A/Z cells, unstimulated or TNFa treated for 1 h (100 units/ml of culture medium). Mutated IkBa expression prevented NF-kB nuclear translocation in OVCAR-3 and MCF7A/Z MT cells. The three control and the three MT cell lines were stimulated with increasing amounts of TNF-a (100 to 1000 units/ml of culture medium) for 24 to 48 h, and cell viability was assessed by a WST-1 colorimetric assay. As shown in Figure 2a , the percentage of cell viability was reduced to 5% when NF-kB is not inducible in OVCAR-3 cells, after 24 h of TNF-a stimulation (1000 U/ml). Similar results were obtained in MT MCF7A/Z, with a cell viability percentage reduced to 20% after 48 h of TNF-a stimulation (1000 U/ml) ( Figure 2b ). These results show that NFkB exerts a cytoprotective role in control OVCAR-3, control MCF7A/Z and control HCT116 cells (Figure 2 and data not shown). Sensitisation to TNF-a in transfected cells was related to the level of IkBa expression and thus to the level of NF-kB inhibition . Although TNF-a did not have any eect on the viability and proliferation of the control cells, a combination of TNF-a and cycloheximide (CHX), a protein synthesis inhibitor, killed 65% of the control cells (data not shown), thus suggesting that protein synthesis is required for the inhibition of TNFa-involved apoptosis.
In order to con®rm that TNF-a induced apoptotic death in our experimental conditions, we compared the cleavage of apoptotic proteins in control and MT cells (Figure 3 ). We performed Western blotting experiments with cellular extracts from TNF-a-treated cells and with antibodies directed against Poly-ADP Ribose Polymerase (PARP), pro-caspase-8, pro-caspase-9 and Bid (Figure 3) . These experiments showed a PARP cleavage only in MT cells, while a caspase-8 cleavage, a decrease of the pro-form of caspase-9 and a decrease of full-length form of Bid were also observed in MT OVCAR-3 cells (Figure 3 ). Caspase-3 activation was also observed in TNF-a-treated MT OVCAR-3 cells (data not shown). These events are hallmarks of apoptosis, and their absence in control cells con®rms the NF-kB anti-apoptotic role.
BclX L and MnSOD expression in WT and MT cells
As NF-kB is known to upregulate the expression of some anti-apoptotic genes, whole cell extracts from control and MT TNF-a-stimulated OVCAR-3 cells were used to compare the expression levels of cIAP1, cIAP2, B¯1/A1, Bcl-X L and MnSOD (Figure 4 and data not shown). Among these proteins, basal Bcl-X L expression level was higher in control OVCAR-3 cells than in MT ones, although no induction could be seen after TNF-a stimulation (Figure 4a ). Moreover, MnSOD induction was detected only in control OVCAR-3 cells (Figure 4b ). This induction was also observed in control MCF7A/Z and HCT116 cells, but not in MT cells, indicating that NF-kB is required for its expression (Figure 4c and data not shown). As neither control nor MT cells constitutively expressed MnSOD, we transfected the MT and control OVCAR-3 cells with an expression vector for MnSOD. After 16 to 24 h, these cells were treated with TNF-a, for 12 to 14 days, in a clonogenic assay (Figure 6c ± e) . Control cells, where NF-kB is not repressed, transfected either with pcDNA 3 or with the expression vector for MnSOD remained resistant to TNF-ainduced apoptosis, and reached con¯uence after a few days of treatment (data not shown). MT cells mocktransfected with pcDNA 3 did not show any increased resistance to TNF-a-induced cell death, as complete cell death or very low number of colonies were observed. MnSOD transfection allowed the formation and growth of TNF-a-resistant MT OVCAR-3 cell colonies (Figure 6c ). The same experiments were performed with a plasmid containing the Bcl-X L cDNA, but this transfection did not have any eect on the TNF-a-induced cell death in MT cells ( Figure  6d) .
The simultaneous transfection of Bcl-X L and MnSOD did not provide a signi®cantly higher resistance to TNF-a than the transfection of MnSOD alone (Figure 6e ). These results indicate that exogenous MnSOD expression restored resistance to TNF-ainduced apoptosis in MT cells. Dixit, 1998; Strasser et al., 2000) . However, we observed a delayed cleavage of procaspase-8, occurring 16 h after TNF-a stimulation. The mechanism could thus be a Type II alternative mechanism, as evidenced by Bid and procaspase-9 cleavage, involving the mitochondrial pathway. This could be correlated by the higher Bcl-X L expression level in control cells, as it has been shown that Bcl-X L may prevent the decrease in mitochondrial membrane potential leading to ROS production during TNF-a-induced apoptosis in T cell hybridoma (Gottlieb et al., 2000) . However, transfection of Bcl-X L cDNA did not improve the resistance of MT cells to TNF-a-induced apoptosis, indicating that preventing this transmembrane potential drop was not sucient to avoid apoptosis in these cells.
MnSOD plays a controversial role in cancer (Macmillan-Crow and Cruthirds, 2001 ). This enzyme is a major antioxidant protein, and its deletion in mice leads to death a few days after birth (Li et al., 1995a; Lebovitz et al., 1996) . It has also been shown that many tumor cell lines express a very low MnSOD level (Oberley and Buettner, 1979) . Moreover, restoration of its activity in transformed cells results in reduced tumor growth (Church et al., 1993; Li et al., 1995b) , and it has recently been shown that MnSOD overexpression can even suppress tumor cell growth (Zhao et al., 2001; Oberley, 2001; Kim et al., 2001) . However, other investigators have shown that p53 represses MnSOD gene expression, and reciprocally (Drane et al., 2001) .
Here, we observed an MnSOD induction in cells where p53 is mutated (OVCAR-3), as well as in cells where p53 is wild-type (MCF7A/Z, HCT116). Our present data demonstrate an induced MnSOD expression following TNF-a stimulation of three epithelial cancer cell lines (OVCAR-3, MCF7A/Z, HCT116). This expression occurs only in the control cells having a normal inducible NF-kB activity, but not in mutated IkBa-overexpressing cells, where NF-kB cannot be activated, indicating that MnSOD is under the control of NF-kB. This MnSOD expression is involved in the anti-apoptotic defence of the wild-type cells against TNF-a-induced apoptosis. Indeed, MT cells are very sensitive to TNF-a-induced apoptosis, and exogenous MnSOD expression in these MT cells partially restored a resistance to TNF-a-induced apoptosis, as observed by clonogenic assays.
TNF-a-induced apoptosis seems to be triggered by ROS (reactive oxygen species), as pre-treatment of the MT cells with various antioxidant compounds (NAC, PDTC, Tiron) protects them against the eect of TNF-a stimulation. Adversely, the glutathione peroxidase mimic Ebselen did not prevent TNF-a-induced apoptosis, as expected in cell lines exhibiting high levels of catalase activity, another enzyme involved in H 2 O 2 elimination (Bonizzi et al., 1997) . Therefore, we can conclude that in the absence of MnSOD expression, TNF-a induced cell death through superoxide anion production. If both MnSOD and catalase are expressed, ROS are rapidly cleared, preventing apoptosis. NF-kB anti-apoptotic activity in our cells is likely due to the induction of MnSOD and the clearance of ROS. Interestingly, in these cells, ROS produced in response to TNF-a are involved in apoptotic cell death but do not lead to NF-kB activation as we have previously demonstrated in epithelial cells (Bonizzi et al., 1996 (Bonizzi et al., , 1997 (Bonizzi et al., , 1999 (Bonizzi et al., , 2000 .
In conclusion, our data demonstrate that ROS production participates in TNF-a cytotoxic eect in 
Materials and methods
Reagents
The human recombinant TNF-a (speci®c activity4 1.0610 8 U/mg) was purchased from Roche (Mannheim, Germany). Cycloheximide (CHX), N-Acetylcysteine (NAC), 4,5-dihydroxy-1,3-benzene-disulfonic acid (Tiron), 2-phenyl-1,2-benzisoselenazol-3[2H]-one (Ebselen) and Pyrrolidine-9-Dithiocarbamate (PDTC) were purchased from Sigma (Steinheim, Germany).
Plasmids
The MnSOD cDNA (from Dr S Chouaib, INSERM 487, Villejuif, France) and the N-terminal HA-tagged S32/36A IkBa cDNA were cloned in pcDNA 3 (Invitrogen), and the constructions were veri®ed by using in vitro transcriptiontranslation system prior to cell transfection. Bcl-X L cDNA was a gift from Dr R Bertrand (UniversiteÂ de MontreÂ al, Canada). The expression vector for Green Fluorescent Protein was purchased from Clontech Laboratories (Palo Alto, CA, USA).
Cell lines
HCT116 human colon carcinoma cells (ATCC CCL 247) were grown in McCoy's 5A modi®ed serum supplemented with 1% L-glutamine (200 mM), 10% (v/v) fetal bovine serum (FBS, Life technologies, Grand Island, NY, USA), penicillin (100 IU/ml) and streptomycin (100 mg/ml). OVCAR-3 ovarian cancer cells (purchased from the ATCC, Rockville, MD, USA) and MCF7A/Z breast cancer cells (kindly supplied by Professor Mareel, University of Gent, Belgium) were maintained in RPMI 1640 medium supplemented with 10% FBS, 1% L-glutamine (200 mM), penicillin (100 IU) and streptomycin (100 mg/ml). The OVCAR-3 were stably transfected either with an empty pcDNA 3 vector or with an expression vector coding for an IkBa protein mutated at serines 32 and 36 and linked to an HA epitope at its aminoterminal end. Individual resistant clones were selected in geneticin (G418 at 500 mg/ml, Life Technologies) and analysed for MT-IkBa expression and NF-kB inhibition. Other cell lines (HCT116 and MCF7A/Z) expressing mutated IkBa protein were previously described (Hellin et al., 1998; Bentires-Alj et al., 1999) . All stably transfected cell lines were cultivated in the same medium as control cells supplemented with geneticin. NAC (10 or 20 mM), PDTC (60 or 120 mM), Tiron (10 mM) and Ebselen (10 mM) were added to the culture medium 60 min before TNF-a treatment.
Protein extraction
Whole cell extracts were made by resuspending the cellular pellets in SDS 1%. The lysates were then boiled for 10 min and protein amounts were quanti®ed with the Micro BCA Protein Assay Reagent (Pierce, Rockford, USA), using a BSA standard solution (bovine serum albumin) as reference.
Nuclear and cytoplasmic extracts were prepared as previously described (Dejardin et al., 1995) . Cytoplasmic buer contained 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES pH 7.9), 0.1 mM EDTA, 2 mM MgCl 2 , 10 mm KCl, 0.2% NP-40 and protease inhibitors (protease inhibitor kit, Roche). The pelleted nuclei were resuspended in nuclear buer (20 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.63 mM NaCl, 25% glycerol, protease inhibitors), incubated for 20 min at 48C, and centrifuged for 30 min at 13 200 r.p.m. Protein amounts were quanti®ed with the Micro BCA Protein Assay Reagent (Pierce, Rockford, USA), using a BSA standard solution (bovine serum albumin) as reference.
Electrophoretic mobility shift assays (EMSA)
Electrophoretic Mobility Shift Assays (EMSA) were performed as described (Bonizzi et al., 1996) . The palindromic kB probe was 5'-TTGGCAACGGCAGGGGAATTCCCC-TCTCCTTAGGTT-3'.
Antibodies
Monoclonal anti-PARP antibody and rabbit polyclonal antibodies against pro-caspase-8 and pro-caspase-9 were purchased from Pharmingen (Becton Dickinson, CA, USA), the goat polyclonal anti-Bid and rabbit polyclonal anti-Bcl-X L antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, USA), and the rabbit polyclonal antiMnSOD and anti-IkBa antibodies were purchased from Upstate Biotechnology (Lake Placid, NY, USA).
Western blotting
Protein extracts (10 mg) were run on 8% or 12% SDS-PAGE gels, depending on the size of the protein to be detected. After transfer to an Immobilon TM -P membrane (PVDF, Millipore), and blocking overnight with TBS-T buer plus 5% non-fat dry milk, the membranes were incubated for 1 h with the appropriate ®rst antibody, washed and then incubated for 1 h with the second horseradish peroxidaseconjugated antibody (DAKO). The reaction was revealed with the enhanced chemoluminescence detection method (ECL kit, Amersham Pharmacia Biotech, UK).
Clonogenic survival assay
Cells were seeded in six-well plates at the concentration of 250 000 cells/well and were transfected the day after with DMRIE-C reagent (Life technologies), according to the manufacturer's recommendations. Cells were transfected either with 3 mg of empty pcDNA 3 or with the MnSOD expression vector. An expression vector for Green Fluorescent Protein (GFP) was used to control the transfection eciency. Sixteen hours after transfection, the culture medium was replaced by fresh medium containing TNF-a (500 U/ml), and this medium was replaced every day for 12 to 14 days. Cell colonies (4 50 cells) were then ®xed with 4% paraformaldehyde and stained with crystal violet.
Cell viability
Stably transfected cells were seeded at the concentration of 10 4 cells (OVCAR-3, MT OVCAR-3, MCF7A/Z and MT MCF7A/Z) per well in¯at-bottomed 96-well plates in 0.2 ml of medium. Twenty-four hours after seeding, the medium was replaced by fresh medium with dierent TNF-a concentrations. After 24 or 48 h of incubation with TNF-a, cell viability was measured by a colorimetric assay based on the cleavage of the tetrazolium salt WST-1 by mitochondrial dehydrogenases in viable cells (Roche), or the living cells, remaining on the bottom of the well, as checked by trypan blue exclusion (data not shown), were counted in quadriplicates.
